ELISABETH TILLEROS: Open Payments
NPI 1437252947 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 27 payments from 11 companies in 2025. Trend: 2023 $127 · 2024 $112 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $161 |
| Novo Nordisk Inc | 5 | $90 |
| Exact Sciences Corporation | 2 | $85 |
| PFIZER INC. | 3 | $75 |
| Lilly USA, LLC | 4 | $72 |
| Abbott Laboratories | 3 | $68 |
| Astellas Pharma US Inc | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: EVENITY, PREVNAR 20, MOUNJARO, FREESTYLE LIBRE 3, Wegovy, Veozah, Auvelity, LEQVIO.
Industry payments across TX — which companies pay providers there.
